Loading...
OTCM
ECIA
Market cap4mUSD
Jul 10, Last price  
0.37USD
1D
0.00%
1Q
-22.59%
Jan 2017
5.74%
Name

Encision Inc

Chart & Performance

D1W1MN
P/E
P/S
0.67
EPS
Div Yield, %
Shrs. gr., 5y
1.49%
Rev. gr., 5y
-5.64%
Revenues
7m
-10.38%
8,053,7589,127,19011,010,03812,065,65912,789,29312,836,00011,616,65712,988,65011,767,00010,546,6379,671,0009,336,0008,870,0008,754,0008,802,4567,670,0007,538,0007,668,0007,349,0006,585,882
Net income
-692k
L+89.01%
-595,133-337,803-90,077-179,318159,817265,0004,564-530,653-616,000-1,781,678-1,383,000-880,000-729,000336,000-236,096-241,430584,734463,340-366,000-691,783
CFO
144k
P
-218,428-420,366-116,959-467,213694,837466,286196,174159,635-315,793111,206-1,432,771-165,83823,000420,000-127,242-229,000220,000-444,000-861,000144,389
Earnings
Aug 12, 2025

Profile

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
IPO date
Jun 25, 1996
Employees
31
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
6,586
-10.38%
7,349
-4.16%
Cost of revenue
7,227
7,652
Unusual Expense (Income)
NOPBT
(641)
(303)
NOPBT Margin
Operating Taxes
42
Tax Rate
NOPAT
(641)
(345)
Net income
(692)
89.01%
(366)
-178.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
(30)
21
BB yield
Debt
Debt current
569
576
Long-term debt
1,831
1,102
Deferred revenue
Other long-term liabilities
Net debt
2,358
1,489
Cash flow
Cash from operating activities
144
(861)
CAPEX
(12)
(183)
Cash from investing activities
(37)
(183)
Cash from financing activities
(254)
284
FCF
(378)
(819)
Balance
Cash
43
189
Long term investments
Excess cash
Stockholders' equity
1,827
2,495
Invested Capital
3,160
3,579
ROIC
ROCE
EV
Common stock shares outstanding
11,770
11,763
Price
Market cap
EV
EBITDA
(556)
(216)
EV/EBITDA
Interest
62
21
Interest/NOPBT